PRDM16 rs4970672: Understanding Your Genetic Bone Density Marker
The rs4970672 variant is a common genetic change located within the PRDM16 gene. It has been studied in the context of bone mineral density and its potential role in susceptibility to osteoporosis.
What each genotype means
Typical BMD risk profile
This genotype represents the more common base pair combination at this position. Large-scale population studies have investigated this variant for potential links to bone mineral density, but current evidence regarding its specific impact on your bone health remains limited and not definitive.
This genotype is common globally, reflecting the high minor allele frequency of the variant which ranges between 0.20 and 0.45 across diverse populations.
Typical BMD risk profile
You carry one copy of each allele. Research into this PRDM16 variant shows that while it has been studied in the context of bone density and osteoporosis, the statistical associations are weak or inconsistent across different populations. This genotype is not considered a reliable predictor of your individual bone health.
This genotype is common globally, reflecting the high minor allele frequency of the variant which ranges between 0.20 and 0.45 across diverse populations.
Typical BMD risk profile
This genotype represents the alternate allele pair at this position. Current scientific literature does not support a strong or consistent link between this specific genotype and clinically significant changes in bone mineral density or osteoporosis risk. You should view this result as part of your general genetic background rather than a specific health indicator.
This genotype is common globally, reflecting the high minor allele frequency of the variant which ranges between 0.20 and 0.45 across diverse populations.
What is rs4970672?
The rs4970672 variant is a single nucleotide polymorphism (SNP), which is a variation at a single position in the DNA sequence. This specific SNP is located within the PRDM16 gene, which provides instructions for making a protein that acts as a transcription factor. Transcription factors are proteins that bind to specific regions of DNA to help control the activity of other genes. Because this variant is located in a gene involved in complex regulatory processes, researchers have investigated whether it might influence how the body maintains bone tissue. It is important to note that SNPs are very common in the human genome and most do not have a direct, singular effect on health. Instead, they often contribute to complex traits in combination with many other genetic and environmental factors.
The Role of the PRDM16 Gene
The PRDM16 gene is widely recognized for its role in the development of brown fat cells, which are specialized for generating heat. Beyond its function in metabolism, researchers have explored the expression of PRDM16 in various tissues, including those involved in skeletal development. Bone mineral density (BMD) is a complex, highly heritable trait that depends on the balance between bone formation and bone resorption. Because PRDM16 is involved in cellular differentiation and gene regulation, scientists have hypothesized that variations in this gene could potentially influence the pathways that maintain bone mass. However, the exact biological mechanism linking this specific SNP to bone density remains a subject of ongoing scientific inquiry rather than a fully established clinical pathway.
Research and Evidence Strength
The association between rs4970672 and bone mineral density is considered to have limited evidence strength. While large-scale genome-wide association studies (GWAS) have identified hundreds of loci associated with bone density and fracture risk, the effect size of any single common variant like rs4970672 is typically very small. Many of these associations are identified through statistical correlations in large populations, which help researchers map the genetic architecture of complex diseases like osteoporosis. Because osteoporosis is influenced by a vast array of genetic markers, lifestyle factors, nutrition, and physical activity, it is difficult to isolate the impact of one specific SNP. Current research suggests that while this variant is a point of interest in genetic studies, it should not be used as a standalone predictor for bone health or disease risk.
Understanding Your Results
If you have received information about your genotype for rs4970672, it is important to view this in the context of your overall health. Genetic testing for common variants associated with complex traits is primarily for educational purposes and does not constitute a medical diagnosis. You cannot change your genotype, but you can influence your bone health through established lifestyle practices, such as maintaining adequate calcium and vitamin D intake, engaging in weight-bearing exercise, and avoiding smoking. If you are concerned about your bone density or your risk of osteoporosis, the most effective step is to consult with a healthcare provider. They can perform clinical assessments, such as a DEXA scan, which are the standard tools for evaluating bone health and determining if medical intervention is necessary.
How common is this variant?
The rs4970672 variant is a common genetic marker found globally, with a minor allele frequency typically ranging between 0.20 and 0.45 across various ancestral groups.
Frequently asked questions
Does having a specific genotype for rs4970672 mean I will get osteoporosis?
No. Genetic variants like rs4970672 only provide a small amount of information regarding your overall risk. Osteoporosis is a complex condition influenced by many genes, age, diet, and lifestyle, and a single SNP cannot predict whether you will develop the condition.
Can I use this genetic information to change my diet?
Genetic information regarding common variants is not a substitute for professional medical or nutritional advice. You should focus on general bone-healthy habits, such as ensuring sufficient calcium and vitamin D intake, which are recommended for everyone regardless of their genotype.
Where can I find more information about my bone health?
The best source for information about your bone health is your primary care physician or an endocrinologist. They can order clinical tests like a bone density scan (DEXA) to provide an accurate assessment of your skeletal health.
Is this variant considered a 'risk' gene?
In the context of GWAS, it is identified as a 'susceptibility' variant, meaning it is statistically associated with a trait. However, it is not a 'disease-causing' mutation in the way that rare, high-impact genetic mutations are.
Sources & further reading
Educational information only, last refreshed 9/24/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs4970672?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in PRDM16
This variant is associated with variations in body mass index and metabolic traits in large-scale genome-wide association studies.
This SNP shows evidence of replication in studies concerning nasal morphology and facial structure.
An established marker in linkage disequilibrium near PRDM16 associated with 3D facial shape differences and chin projection.
This variant near PRDM16 is associated with normal human facial morphology variation, particularly chin and lower-face width.
This SNP is linked to craniofacial development and has been replicated in studies of facial shape variation.
Pleiotropic genomic risk variant fine-mapped to age-related retinal and macular thickness traits.